Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

    Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

    FromThe Lancet Oncology in conversation with

    Start listeningView podcast show

    Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

    FromThe Lancet Oncology in conversation with

    ratings:
    Length:
    18 minutes
    Released:
    Mar 2, 2017
    Format:
    Podcast episode

    Description

    Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
    Released:
    Mar 2, 2017
    Format:
    Podcast episode

    Titles in the series (100)

    Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.